Tudor Investment Corp’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-155,734
Closed -$1.79M 2273
2024
Q1
$1.79M Buy
+155,734
New +$1.32M 0.01% 1070
2023
Q4
Sell
-205,876
Closed -$1.87M 2315
2023
Q3
$1.87M Buy
205,876
+158,030
+330% +$1.89M 0.02% 963
2023
Q2
$582K Buy
+47,846
New +$533K 0.01% 1623
2022
Q4
Sell
-150,408
Closed -$2.83M 2319
2022
Q3
$2.83M Sell
150,408
-29,118
-16% -$598K 0.06% 406
2022
Q2
$3.24M Buy
179,526
+46,499
+35% +$755K 0.09% 299
2022
Q1
$2.13M Buy
133,027
+79,219
+147% +$1.42M 0.05% 520
2021
Q4
$1.32M Buy
+53,808
New +$1.26M 0.02% 852
2021
Q3
Sell
-9,905
Closed -$271K 2409
2021
Q2
$271K Buy
+9,905
New +$282K 0.01% 1389
2019
Q4
Sell
-500,004
Closed -$5.09M 1124
2019
Q3
$5.09M Hold
500,004
0.17% 123
2019
Q2
$5.07M Hold
500,004
0.14% 98
2019
Q1
$5M Hold
500,004
0.21% 98
2018
Q4
$4.92M Buy
+500,004
New +$4.9M 0.1% 58

Other funds holding AHCO

Tudor Investment Corp's AHCO Position: Q2 2024 in Review

Tudor Investment Corp sold out of AdaptHealth (AHCO) in Q2 2024, closing a stake of 155,734 shares — an estimated $1.79M sold.

Tudor Investment Corp first reported a position in AHCO in Q4 2018 and held it in 12 quarters. The position peaked at $5.09M in Q3 2019. 207 funds tracked by Wall St. Rank hold AHCO as of Q2 2024.

  • Tudor Investment Corp reported no remaining AdaptHealth position as of Q2 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 155,734 AdaptHealth shares in Q2 2024, an estimated $1.79M.
  • Tudor Investment Corp first reported a position in AdaptHealth in Q4 2018 and held it in 12 quarters.
  • Tudor Investment Corp's AdaptHealth position peaked at $5.09M in Q3 2019.
  • 207 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2024.

Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.